Trending

Vectura

Rumours of $1.65bn GSK bid for respiratory partners Vectura

Rumours of $1.65bn GSK bid for respiratory partners Vectura

GlaxoSmithKline could be poised to acquire its respiratory partner, UK biotech Vectura, for $1.65bn.

X

Rumours of $1.65bn GSK bid for respiratory partners Vectura

https://pharmaphorum.com/news/rumours-1-65bn-gsk-bid-respiratory-partners-vectura/

Vectura and Hikma to develop US asthma generic

Vectura and Hikma to develop US asthma generic

Firms extend existing respiratory deal.

X

Vectura and Hikma to develop US asthma generic

https://pharmaphorum.com/news/vectura-hikma-develop-us-asthma-generic/

Vectura’s Flutiform fails in COPD trial

Vectura’s Flutiform fails in COPD trial

EU filing plans halted after phase 3 setback.

X

Vectura’s Flutiform fails in COPD trial

https://pharmaphorum.com/news/vecturas-flutiform-fails-copd-trial/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com